PI3Kδ and PI3Kγ:: partners in crime in inflammation in rheumatoid arthritis and beyond?

被引：351

作者：

Rommel, Christian ^{[1
]}

Camps, Montserrat ^{[1
]}

Ji, Hong ^{[1
]}

机构：

[1] Merck Serono Int SA, CH-1211 Geneva, Switzerland

来源：

NATURE REVIEWS IMMUNOLOGY | 2007年 / 7卷 / 03期

关键词：

D O I：

10.1038/nri2036

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Dysregulated signal transduction in innate and adaptive immune cells is known to be associated with the development of various autoimmune and inflammatory diseases. Consequently, targeting intracellular signalling of the pro-inflammatory cytokine network heralds hope for the next generation of anti-inflammatory drugs. Phosphoinositide 3-kinases (PI3Ks) generate lipid-based second messengers that control an array of intracellular signalling pathways that are known to have important roles in leukocytes. In light of the recent progress in the development of selective PI3K inhibitors, and the beneficial effects of these inhibitors in models of acute and chronic inflammatory disorders, we discuss the therapeutic potential of blocking PI3K isoforms for the treatment of rheumatoid arthritis and other immune-mediated diseases.

引用

收藏

页码：191 / 201

页数：11

相关论文

共 127 条

[1] Essential role for the p110δ phosphoinositide 3-kinase in the allergic response [J].

Ali, K ;

Bilancio, A ;

Thomas, M ;

Pearce, W ;

Gilfillan, AM ;

Tkaczyk, C ;

Kuehn, N ;

Gray, A ;

Giddings, J ;

Peskett, E ;

Fox, R ;

Bruce, I ;

Walker, C ;

Sawyer, C ;

Okkenhaug, K ;

Finan, P ;

Vanhaesebroeck, B .

NATURE, 2004, 431 (7011) :1007-1011

[2] Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion [J].

Barber, DF ;

Bartolomé, A ;

Hernandez, C ;

Flores, JM ;

Fernandez-Arias, C ;

Rodríguez-Borlado, L ;

Hirsch, E ;

Wymann, M ;

Balomenos, D ;

Carrera, AC .

JOURNAL OF IMMUNOLOGY, 2006, 176 (01) :589-593

[3] PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus [J].

Barber, DF ;

Bartolomé, A ;

Hernandez, C ;

Flores, JM ;

Redondo, C ;

Fernandez-Arias, C ;

Camps, M ;

Ruckle, T ;

Schwarz, MK ;

Rodríguez, S ;

Martinez-A, C ;

Balomenos, D ;

Rommel, C ;

Carrera, AC .

NATURE MEDICINE, 2005, 11 (09) :933-935

[4] Mast cells in autoimmune disease [J].

Benoist, C ;

Mathis, D .

NATURE, 2002, 420 (6917) :875-878

[5] A revival of the B cell paradigm for rheumatoid arthritis pathogenesis? [J].

Benoist, C ;

Mathis, D .

ARTHRITIS RESEARCH, 2000, 2 (02) :90-94

[6]

Bernstein HG, 1998, CELL MOL BIOL, V44, P973

[7] Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase [J].

Bi, L ;

Okabe, I ;

Bernard, DJ ;

Wynshaw-Boris, A ;

Nussbaum, RL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10963-10968

[8] Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase [J].

Bi, L ;

Okabe, I ;

Bernard, DJ ;

Nussbaum, RL .

MAMMALIAN GENOME, 2002, 13 (03) :169-172

[9] Key role of the p110δ isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling:: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells [J].

Bilancio, A ;

Okkenhaug, K ;

Camps, M ;

Emery, JL ;

Ruckle, T ;

Rommel, C ;

Vanhaesebroeck, B .

BLOOD, 2006, 107 (02) :642-650

[10]

Borlado LR, 2000, FASEB J, V14, P895

← 1 2 3 4 5 6 7 8 9 10 →